Protege Intima

Non-surgical lifting and rejuvenation of the labia.

Protege Intima is the first RF system for remodeling of the labia.
Protege Intima delivers a measurable clinical result with maximum comfort and safety.

Protege Intima offers a solution for the following concerns:
- dissatisfaction with the appearance of the intimate area
- physical discomfort
- pain during intercourse
- chronic irritation of the vulvar area
- laxity, stretching, and sagging of the labia

Advantages:
- short treatment time
- excellent procedure tolerability
- no recovery period
- recommended course: 4–6 sessions

Protege Intima uses an innovative energy delivery system that breaks down old collagen and triggers fibroblasts to produce new collagen fibers.
Protege Intima technology ensures high safety and confidence in even heating of the treatment zone.

You can undergo treatment with us anonymously, after discussing your concern with the doctor in advance.

Phone: + 998-90-983 31 01
+ 998-90-911 58 17

Address:
Uzbekistan, Tashkent, Taraqqiyot Street, 105
(landmark: old TashMI)

“HOREV MEDICAL CENTER” WISHES YOU GOOD HEALTH!

People with type 1 diabetes are more likely to face life-threatening complications when using cannabis, The Daily Mail warns. A survey of 450 diabetic patients found that 30% used the plant-based drug.
Compared with those who did not use cannabis, the rest were roughly twice as likely to develop a complication known as diabetic ketoacidosis. This complication develops when blood sugar remains elevated for too long and the body produces high levels of ketones. If left untreated, it can lead to dehydration, brain swelling, coma, and death.
As part of the study, scientists drew blood samples from the volunteers to measure their glycated hemoglobin (A1c), which reflects average blood sugar over roughly three months. People with type 1 diabetes are usually advised to keep A1c below 6.5%. Among cannabis users, the average was 8.4%, raising the risk of heart attacks, strokes, kidney failure, blindness, amputations, and death. By comparison, those who did not use the plant-based drug averaged 7.6%.